Following injection side effects, Design Therapeutics to reformulate Friedreich's ataxia drug, delay trial timeline
Design Therapeutics said Tuesday morning that it was planning to reformulate its Friedreich’s ataxia drug following injection site reactions in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.